Join BJS Academy
BJS Academy>Randomized clinical ...>Effect of laparoscop...
Normal View Dyslexic View

Effect of laparoscopic and open pancreaticoduodenectomy for pancreatic or periampullary tumors. Three-year follow-up of a randomized clinical trial.

27 June 2024
Randomized clinical trials HPB
Qin T, Zhang H, Pan S, Liu J, Li D, Chen R et al, for the Minimally Invasive Treatment Group in the Pancreatic Disease Branch of China’s International Exchange and Promotion Association for Medicine and Healthcare (MITG-P-CPAM).

Ann Surg 2024; 279: 605-612. 

This multicentre study from China included 656 procedures. 3-year overall survival was 59.1 per cent after laparoscopic  surgery for malignant disease versus 54.3 per cent after open surgery (P=0.33).

Comment: Big study confirming long term survival after laparoscopic surgery no worse than after open surgery.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct005
Randomized clinical trials
Randomized clinical trials
HPB
Effect of laparoscopic and open pancreaticoduodenectomy for pancreatic or periampullary tumors. Three-year follow-up of a randomized clinical trial.
Qin T, Zhang H, Pan S, Liu J, Li D, Chen R et al, for the Minimally Invasive Treatment Group in the Pancreatic Disease Branch of China’s International Exchange and Promotion Association for Medicine and Healthcare (MITG-P-CPAM).
27062024
Ann Surg 2024; 279: 605-612. 
This multicentre study from China included 656 procedures. 3-year overall survival was 59.1 per cent after laparoscopic  surgery for malignant disease versus 54.3 per cent after open surgery (P=0.33).
Comment: Big study confirming long term survival after laparoscopic surgery no worse than after open surgery.
Published on: 27 June 2024
Article ID: rct005

Related articles

Temporary portocaval shunt provides superior intraoperative hemodynamics and reduces blood loss and duration of surgery in live donor liver transplantation. A randomized controlled trial.

Kumar M, Patil NS, Mohapatra N, Sindwani G, Dhingra U, Yadav A et al.
Ann Surg 2024; 279: 932-944.

16 August 2024

Upfront endoscopic necrosectomy or step-up endoscopic approach for infected necrotising pancreatitis (DESTIN): a single-blinded, multicentre, randomised trial.

Bang JY, Lakhtakia S, Thakkar S, Buxbaum JL, Waxman I, Sutton B et al, on behalf of the United States Pancreatic Disease Study Group.

16 August 2024

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Labori KJ, Bratlie SO, Andersson B, Angelsen J-H, Biorserud C, Bjornsson B et al, for the Nordic Pancreatic Cancer Trial-1 study group.

30 August 2024
Home
  • Normal view
  • Dyslexic view
Info
Copied!